Total Payments
$4,760
2024 Payments
$26.30
Companies
28
Transactions
376
Medicare Patients
21,181
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$4,748 (99.7%)
Education$12.00 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,748 | 375 | 99.7% |
| Education | $12.00 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $866.84 | 59 | $0 (2020) |
| PFIZER INC. | $714.71 | 85 | $0 (2021) |
| Novo Nordisk Inc | $551.68 | 48 | $0 (2024) |
| GlaxoSmithKline, LLC. | $397.74 | 24 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $341.09 | 26 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $289.90 | 21 | $0 (2021) |
| Amgen Inc. | $269.69 | 18 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $205.23 | 15 | $0 (2021) |
| Lilly USA, LLC | $192.17 | 14 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $147.97 | 12 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26.30 | 2 | GlaxoSmithKline, LLC. ($13.16) |
| 2023 | $68.10 | 4 | GlaxoSmithKline, LLC. ($40.14) |
| 2022 | $161.25 | 11 | ABBVIE INC. ($42.79) |
| 2021 | $361.51 | 24 | PFIZER INC. ($104.50) |
| 2020 | $243.75 | 17 | PFIZER INC. ($75.09) |
| 2019 | $1,035 | 86 | AstraZeneca Pharmaceuticals LP ($335.11) |
| 2018 | $1,189 | 99 | AstraZeneca Pharmaceuticals LP ($224.36) |
| 2017 | $1,675 | 133 | AstraZeneca Pharmaceuticals LP ($260.64) |
All Payment Transactions
376 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: RESPIRATORY | ||||||
| 05/16/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Diabetes | ||||||
| 12/12/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: RESPIRATORY | ||||||
| 04/06/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: RESPIRATORY | ||||||
| 03/13/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.50 | General |
| Category: Cardiovascular | ||||||
| 07/27/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: NEUROSCIENCE | ||||||
| 06/01/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: Diabetes | ||||||
| 05/31/2022 | Horizon Therapeutics plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: PENNSAID | ||||||
| 05/19/2022 | SANOFI PASTEUR INC. | VAXELIS (Biological), QUADRACEL, MENQUADFI | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: Vaccines | ||||||
| 05/09/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.59 | General |
| Category: Inflammation | ||||||
| 04/21/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: NEUROSCIENCE | ||||||
| 03/31/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: VACCINES | ||||||
| 03/08/2022 | Corium, LLC | AZSTARYS (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 02/01/2022 | Xeris Pharmaceuticals, Inc. | GVOKE PFS (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Diabetes | ||||||
| 01/05/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: NEUROSCIENCE | ||||||
| 11/29/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/22/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.11 | General |
| Category: Cardiovascular | ||||||
| 11/17/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), STEGLUJAN, STEGLATRO | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/08/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/07/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUVIA, SEGLUROMET | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: NEUROSCIENCE | ||||||
| 08/11/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 51 | 5,467 | 10,434 | $706,984 | $354,349 |
| 2022 | 50 | 5,462 | 10,893 | $755,659 | $385,172 |
| 2021 | 59 | 5,690 | 10,729 | $787,592 | $417,315 |
| 2020 | 55 | 4,562 | 9,337 | $667,031 | $309,261 |
Total Patients
21,181
Total Services
41,393
Medicare Billing
$1.5M
Procedure Codes
215
All Medicare Procedures & Services
215 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 514 | 2,091 | $303,195 | $157,478 | 51.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 426 | 426 | $68,160 | $49,018 | 71.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 354 | 719 | $79,080 | $41,370 | 52.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 51 | 61 | $18,910 | $11,920 | 63.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 479 | 1,035 | $12,420 | $8,671 | 69.8% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 158 | 209 | $17,765 | $8,394 | 47.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 112 | 112 | $8,940 | $8,317 | 93.0% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 456 | 456 | $12,768 | $7,386 | 57.8% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 189 | 349 | $24,430 | $7,199 | 29.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 437 | 437 | $12,236 | $7,059 | 57.7% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 28 | 30 | $6,900 | $4,248 | 61.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 204 | 457 | $19,159 | $3,976 | 20.8% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 96 | 230 | $8,050 | $3,698 | 45.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 126 | 126 | $5,292 | $3,479 | 65.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 21 | 21 | $6,300 | $2,953 | 46.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 160 | 252 | $7,560 | $2,346 | 31.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 218 | 238 | $7,135 | $2,045 | 28.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $4,700 | $1,728 | 36.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 20 | 20 | $5,700 | $1,652 | 29.0% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 191 | 504 | $3,528 | $1,598 | 45.3% |
| 74019 | X-ray of abdomen, 2 views | Office | 2023 | 40 | 56 | $4,200 | $1,345 | 32.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $3,255 | $1,242 | 38.2% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 191 | 201 | $2,412 | $1,216 | 50.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 20 | 29 | $4,060 | $1,188 | 29.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 12 | 12 | $4,620 | $1,185 | 25.6% |
About Dr. Michael Higginbotham, MD
Dr. Michael Higginbotham, MD is a Family Medicine healthcare provider based in Rockport, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619992377.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Higginbotham, MD has received a total of $4,760 in payments from pharmaceutical and medical device companies, with $26.30 received in 2024. These payments were reported across 376 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($4,748).
As a Medicare-enrolled provider, Higginbotham has provided services to 21,181 Medicare beneficiaries, totaling 41,393 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 215 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Rockport, AR
- Active Since 07/13/2006
- Last Updated 09/21/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1619992377
Products in Payments
- FARXIGA (Drug) $542.03
- CHANTIX (Drug) $297.54
- SYMBICORT (Drug) $187.67
- ELIQUIS (Drug) $182.06
- Ozempic (Drug) $180.42
- Victoza (Drug) $167.54
- XARELTO (Drug) $159.95
- JANUVIA (Drug) $153.50
- ENTRESTO (Drug) $147.97
- ANORO (Drug) $140.67
- TOUJEO (Drug) $130.30
- INVOKANA (Drug) $129.95
- LYRICA (Drug) $117.12
- TRELEGY ELLIPTA (Drug) $115.80
- SOLIQUA (Drug) $111.86
- VRAYLAR (Drug) $104.82
- BREO (Drug) $103.14
- Prolia (Biological) $102.33
- XIFAXAN (Drug) $98.36
- HUMALOG (Drug) $93.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Rockport
Rimantas Kazakevicius, Md, MD
Family Medicine — Payments: $5,849
Family Medicine $5,849
Susan Martin, Md, MD
Family Medicine — Payments: $5,045
Family Medicine $5,045
Mario Perez, D.o, D.O
Family Medicine — Payments: $4,781
Family Medicine $4,781
Dr. Yvette Alvarez, D.o, D.O
Family Medicine — Payments: $3,320
Family Medicine $3,320
Dr. Katrina Erickson, M.d, M.D
Family Medicine — Payments: $3,134
Family Medicine $3,134
John Root, Md, MD
Family Medicine — Payments: $1,013
Family Medicine $1,013